![Josette-Nicole Mahy Géhenne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Josette-Nicole Mahy Géhenne
Keine laufenden Positionen mehr
Profil
Josette-Nicole Mahy Géhenne is the founder of Neurotec Pharma SL, which was founded in 2006.
She held the title of Scientific Consultant at the company.
Dr. Mahy Géhenne earned an MBA degree from Université de Caen Basse-Normandie in 1973 and also completed undergraduate studies at the same institution.
Ehemalige bekannte Positionen von Josette-Nicole Mahy Géhenne
Unternehmen | Position | Ende |
---|---|---|
Neurotec Pharma SL
![]() Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Gründer | - |
Ausbildung von Josette-Nicole Mahy Géhenne
Université de Caen Basse-Normandie | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Neurotec Pharma SL
![]() Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Health Technology |